‘A very paternalistic attitude’: why is female desire still not taken seriously?
In documentary The Pink Pill, the fight to provide access to the so-called ‘female Viagra’ exposes an industry that still discounts the needs of women
Barbara Gattuso had been happily married for decades when she signed up, in the late 2000s, for a clinical trial involving a potentially revolutionary new drug. She and her husband had once had a fulfilling sex life, both pre- and post-children. But at some point during her perimenopausal years, her desire disappeared. It wasn’t stress, fatigue or relationship issues, though her lack of libido certainly contributed to those. It was more like a mysterious evaporation – like “somebody pulled the plug”, as she recalls in a new documentary on flibanserin, the experimental drug that proffered potential relief.
Originally developed as an anti-depressant by the German company Boehringer Ingelheim, flibanserin had instead shown promise as a treatment for low female libido, working on neurotransmitters in the so-called “sex center” of the brain. In a video from that trial filmed by Dr Irwin Goldstein, the “godfather of sexual medicine” and a key consultant on Viagra – that revolutionary blue pill for men with erectile dysfunction – Gattuso appears nearly giddy. She was chasing her husband around again, she said. She felt “phenomenal”, like a “new woman on this drug”. She was plugged in.
Continue reading...
© Photograph: Paramount

© Photograph: Paramount

© Photograph: Paramount